Three things to know:
1. The robot has been approved for laparoscopy for general surgery, gynecology, urology and specific thoracic procedures.
2. Senhance’s goal is to improve the precision, senses and control of surgeons in minimally invasive laparoscopic procedures.
3. “Japan is second only to the U.S. as the world’s largest surgical robotics market” and “creates a considerable market opportunity for Senhance,” said Todd M. Pope, president and CEO of TransEnterix.
More articles on devices:
Exactech acquires EPIC Extremity, expands foot and ankle portfolio — 4 insights
Surgeon co-founded device company launches orthopedic drill
10 major updates from NuVasive in the last 6 months
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
